Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ
Zmień bibliotekę

Wyszukujesz frazę ""Urinary Bladder Neoplasms"" wg kryterium: Temat


Tytuł :
Mesenchymal neoplasms of the urinary bladder: a comprehensive review with focus on cross-sectional imaging findings.
Autorzy :
Balasubramanya R; Department of Radiology, Thomas Jefferson University Hospital, Philadelphia, USA.
Shanbhogue AK; New York University School of Medicine, New York, USA.
Ramani NS; Department of Pathology, Michael E DeBakey VA Medical Center, Houston, USA.
Morani AC; Department of Abdominal Imaging, University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Unit 1473, Houston, TX, 77030, USA.
Khandelwal A; Mayo Clinic, Rochester, USA.
Prasad SR; Department of Abdominal Imaging, University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Unit 1473, Houston, TX, 77030, USA. .
Pokaż więcej
Źródło :
Abdominal radiology (New York) [Abdom Radiol (NY)] 2022 Aug; Vol. 47 (8), pp. 2881-2895. Date of Electronic Publication: 2022 Jun 15.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Urinary Bladder*/pathology
Urinary Bladder Neoplasms*/diagnostic imaging
Urinary Bladder Neoplasms*/pathology
Diagnostic Imaging ; Humans ; Pelvis/pathology
Czasopismo naukowe
Tytuł :
Systematic Review of the Incidence of and Risk Factors for Urothelial Cancers and Renal Cell Carcinoma Among Patients with Haematuria.
Autorzy :
Rai BP; Department of Urology, Freeman Hospital, The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK. Electronic address: .
Luis Dominguez Escrig J; Department of Urology, Fundación Instituto Valenciano de Oncología, Valencia, Spain.
Vale L; Department of Urology, Centro Hospital Universitário S. João, Porto, University of Porto, Porto, Portugal.
Kuusk T; Department of Urology, Darent Valley Hospital, Dartford and Gravesham NHS Trust, Dartford, UK.
Capoun O; Department of Urology, General University Hospital, First Faculty of Medicine, Charles University, Prague, Czech Republic.
Soukup V; Department of Urology, General University Hospital, First Faculty of Medicine, Charles University, Prague, Czech Republic.
Bruins HM; Department of Urology, Zuyderland Medical Center, Sittard-Geleen-Heerlen, The Netherlands.
Yuan Y; Department of Medicine, Health Science Centre, McMaster University, Hamilton, ON, Canada.
Violette PD; Department of Health Research Methods, Evidence and Impact, McMaster University, Hamilton, ON, Canada; Department of Surgery, Division of Urology, McMaster University, Hamilton, ON, Canada.
Santesso N; Department of Health Research Methods, Evidence and Impact, McMaster University, Hamilton, ON, Canada; Michael G. DeGroote Cochrane Canada Centre, McMaster University, Hamilton, ON, Canada.
van Rhijn BWG; Department of Surgical Oncology (Urology), Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.
Hugh Mostafid A; Department of Urology, Royal Surrey County Hospital, Guildford, UK.
Imran Omar M; Academic Urology Unit, University of Aberdeen, Aberdeen, UK.
Pokaż więcej
Źródło :
European urology [Eur Urol] 2022 Aug; Vol. 82 (2), pp. 182-192. Date of Electronic Publication: 2022 Apr 05.
Typ publikacji :
Journal Article; Review; Systematic Review
MeSH Terms :
Carcinoma, Renal Cell*/complications
Carcinoma, Renal Cell*/epidemiology
Carcinoma, Transitional Cell*/complications
Carcinoma, Transitional Cell*/epidemiology
Kidney Neoplasms*/complications
Kidney Neoplasms*/epidemiology
Urinary Bladder Neoplasms*/complications
Urinary Bladder Neoplasms*/epidemiology
Cross-Sectional Studies ; Hematuria/epidemiology ; Hematuria/etiology ; Humans ; Incidence ; Male ; Prospective Studies ; Retrospective Studies ; Risk Factors
Czasopismo naukowe
Tytuł :
VI-RADS score system - A primer for urologists.
Autorzy :
Nicola R; Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.
Pecoraro M; Department of Radiological Sciences, Oncology and Pathology, Sapienza University of Rome, Italy.
Lucciola S; Department of Radiological Sciences, Oncology and Pathology, Sapienza University of Rome, Italy.
Dos Reis RB; Departamento de Cirurgia, Divisão de Urologia - Faculdade de Medicina de Ribeirão Preto - USP, Ribeirão Preto, SP, Brasil.
Narumi Y; Department of Health Care, Kyoto Tachibana, Kyoto, Japan.
Panebianco V; Department of Radiological Sciences, Oncology and Pathology, Sapienza University of Rome, Italy.
Muglia VF; Departamento de Imagens Médicas, Oncologia e Hematologia - Divisão de Imagem, Faculdade de Medicina de Ribeirão Preto - USP, Ribeirão Preto, SP, Brasil.
Pokaż więcej
Źródło :
International braz j urol : official journal of the Brazilian Society of Urology [Int Braz J Urol] 2022 Jul-Aug; Vol. 48 (4), pp. 609-622.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Multiparametric Magnetic Resonance Imaging*
Urinary Bladder Neoplasms*/diagnostic imaging
Urinary Bladder Neoplasms*/pathology
Humans ; Magnetic Resonance Imaging/methods ; Neoplasm Recurrence, Local/pathology ; Urinary Bladder/pathology ; Urologists
Czasopismo naukowe
Tytuł :
Next-generation Proteomics-Based Discovery, Verification, and Validation of Urine Biomarkers for Bladder Cancer Diagnosis.
Autorzy :
Suh J; Department of Urology, Asan Medicine Center, Seoul, Korea.; Department of Urology, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea.
Han D; Proteomics Core Facility, Seoul National University Hospital Biomedical research institute, Seoul, Korea.
Ku JH; Department of Urology, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea.
Kim HH; Department of Urology, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea.
Kwak C; Department of Urology, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea.
Jeong CW; Department of Urology, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea.
Pokaż więcej
Źródło :
Cancer research and treatment [Cancer Res Treat] 2022 Jul; Vol. 54 (3), pp. 882-893. Date of Electronic Publication: 2021 Oct 09.
Typ publikacji :
Journal Article
MeSH Terms :
Carcinoma, Transitional Cell*
Urinary Bladder Neoplasms*/diagnosis
Urinary Bladder Neoplasms*/pathology
Biomarkers, Tumor/metabolism ; Humans ; Proteomics/methods ; Urinary Bladder/pathology
Czasopismo naukowe
Tytuł :
Genomic Sequencing for Bladder Urothelial Carcinoma and Its Clinical Implications for Immunotherapy.
Autorzy :
Kim R; Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
Hong JY; Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
Lee J; Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
Kwon GY; Department of Pathology and Translational Genomics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
Jeong BC; Department of Urology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
Park SH; Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
Pokaż więcej
Źródło :
Cancer research and treatment [Cancer Res Treat] 2022 Jul; Vol. 54 (3), pp. 894-906. Date of Electronic Publication: 2021 Nov 17.
Typ publikacji :
Journal Article
MeSH Terms :
Carcinoma, Transitional Cell*
Urinary Bladder Neoplasms*/genetics
Urinary Bladder Neoplasms*/therapy
B7-H1 Antigen/genetics ; B7-H1 Antigen/metabolism ; Biomarkers, Tumor/genetics ; Biomarkers, Tumor/metabolism ; Genomics ; Humans ; Immunotherapy ; Mutation ; Tumor Microenvironment ; Urinary Bladder
Czasopismo naukowe
Tytuł :
Detecting the muscle invasiveness of bladder cancer: An application of diffusion kurtosis imaging and tumor contact length.
Autorzy :
Li Q; Department of Radiology, Shanghai Institute of Medical Imaging, Zhongshan Hospital, Fudan University, Shanghai, China; Department of Cancer Center, Zhongshan Hospital, Fudan University, Shanghai, China.
Cao B; Department of Radiology, Shanghai Institute of Medical Imaging, Zhongshan Hospital, Fudan University, Shanghai, China; Department of Cancer Center, Zhongshan Hospital, Fudan University, Shanghai, China.
Liu K; Department of Radiology, Shanghai Institute of Medical Imaging, Zhongshan Hospital, Fudan University, Shanghai, China.
Sun H; Department of Radiology, Shanghai Institute of Medical Imaging, Zhongshan Hospital, Fudan University, Shanghai, China; Department of Cancer Center, Zhongshan Hospital, Fudan University, Shanghai, China.
Ding Y; Department of Radiology, Shanghai Institute of Medical Imaging, Zhongshan Hospital, Fudan University, Shanghai, China; Department of Cancer Center, Zhongshan Hospital, Fudan University, Shanghai, China.
Yan C; Department of Radiology, Shanghai Institute of Medical Imaging, Zhongshan Hospital, Fudan University, Shanghai, China.
Wu PY; GE Healthcare, MR Research China, Beijing, China.
Dai C; Department of Radiology, Shanghai Institute of Medical Imaging, Zhongshan Hospital, Fudan University, Shanghai, China; Department of Cancer Center, Zhongshan Hospital, Fudan University, Shanghai, China.
Rao S; Department of Radiology, Shanghai Institute of Medical Imaging, Zhongshan Hospital, Fudan University, Shanghai, China; Department of Cancer Center, Zhongshan Hospital, Fudan University, Shanghai, China.
Zeng M; Department of Radiology, Shanghai Institute of Medical Imaging, Zhongshan Hospital, Fudan University, Shanghai, China; Department of Cancer Center, Zhongshan Hospital, Fudan University, Shanghai, China.
Jiang S; Department of Urology, Zhongshan Hospital, Fudan University, Shanghai, China; Department of Urology, Zhongshan Hospital Wusong Branch, Fudan University, Shanghai, China.
Zhou J; Department of Radiology, Shanghai Institute of Medical Imaging, Zhongshan Hospital, Fudan University, Shanghai, China; Department of Cancer Center, Zhongshan Hospital, Fudan University, Shanghai, China; Department of Radiology, Xiamen Branch, Zhongshan Hospital, Fudan University, Fujian Province, China. Electronic address: .
Pokaż więcej
Źródło :
European journal of radiology [Eur J Radiol] 2022 Jun; Vol. 151, pp. 110329. Date of Electronic Publication: 2022 Apr 22.
Typ publikacji :
Journal Article
MeSH Terms :
Multiparametric Magnetic Resonance Imaging*
Urinary Bladder Neoplasms*/diagnostic imaging
Urinary Bladder Neoplasms*/surgery
Diffusion Magnetic Resonance Imaging ; Diffusion Tensor Imaging ; Female ; Humans ; Magnetic Resonance Imaging ; Male ; Muscles ; Retrospective Studies
Czasopismo naukowe
Tytuł :
Association of Biochemically Verified Post-Diagnosis Smoking and Nonmuscle-Invasive Bladder Cancer Recurrence Risk.
Autorzy :
Furberg H; Memorial Sloan Kettering Cancer Center, New York, New York.
Petruzella S; Memorial Sloan Kettering Cancer Center, New York, New York.
Whiting K; Memorial Sloan Kettering Cancer Center, New York, New York.
Stein E; Memorial Sloan Kettering Cancer Center, New York, New York.
Orlow I; Memorial Sloan Kettering Cancer Center, New York, New York.
Kenney J; Memorial Sloan Kettering Cancer Center, New York, New York.
Corrales-Guerrero S; Memorial Sloan Kettering Cancer Center, New York, New York.
Benfante N; Memorial Sloan Kettering Cancer Center, New York, New York.
Cha EK; Memorial Sloan Kettering Cancer Center, New York, New York.
Donahue TF; Memorial Sloan Kettering Cancer Center, New York, New York.
Donat SM; Memorial Sloan Kettering Cancer Center, New York, New York.
Herr HW; Memorial Sloan Kettering Cancer Center, New York, New York.
Matulewicz RS; Memorial Sloan Kettering Cancer Center, New York, New York.
Pietzak E; Memorial Sloan Kettering Cancer Center, New York, New York.
Dalbagni G; Memorial Sloan Kettering Cancer Center, New York, New York.
Ostroff J; Memorial Sloan Kettering Cancer Center, New York, New York.
Bochner BH; Memorial Sloan Kettering Cancer Center, New York, New York.
Pokaż więcej
Źródło :
The Journal of urology [J Urol] 2022 Jun; Vol. 207 (6), pp. 1200-1206. Date of Electronic Publication: 2022 Jan 27.
Typ publikacji :
Journal Article
MeSH Terms :
Neoplasm Invasiveness*/pathology
Smoking*/adverse effects
Smoking*/epidemiology
Urinary Bladder Neoplasms*/diagnosis
Urinary Bladder Neoplasms*/drug therapy
Urinary Bladder Neoplasms*/etiology
Administration, Intravesical ; Aged ; BCG Vaccine/therapeutic use ; Female ; Humans ; Male ; Neoplasm Recurrence, Local/diagnosis ; Neoplasm Recurrence, Local/drug therapy ; Neoplasm Recurrence, Local/epidemiology ; Prospective Studies
Czasopismo naukowe
Tytuł :
Staging F-fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Changes Treatment Recommendation in Invasive Bladder Cancer.
Autorzy :
Voskuilen CS; Department of Urology, The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.
van Gennep EJ; Department of Urology, The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands; Department of Urology, Leiden University Medical Center, Leiden, The Netherlands.
Einerhand SMH; Department of Urology, The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.
Vegt E; Department of Nuclear Medicine, The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands; Department of Radiology and Nuclear Medicine, Erasmus MC University Medical Center, Rotterdam, The Netherlands.
Donswijk ML; Department of Nuclear Medicine, The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.
Bruining A; Department of Radiology, The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.
van der Poel HG; Department of Urology, The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.
Horenblas S; Department of Urology, The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.
Hendricksen K; Department of Urology, The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.
van Rhijn BWG; Department of Urology, The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands; Department of Urology, Caritas St. Josef Medical Center, University of Regensburg, Regensburg, Germany.
Mertens LS; Department of Urology, The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands. Electronic address: .
Pokaż więcej
Źródło :
European urology oncology [Eur Urol Oncol] 2022 Jun; Vol. 5 (3), pp. 366-369. Date of Electronic Publication: 2021 Feb 11.
Typ publikacji :
Journal Article
MeSH Terms :
Fluorodeoxyglucose F18*
Urinary Bladder Neoplasms*/diagnostic imaging
Urinary Bladder Neoplasms*/therapy
Humans ; Lymphatic Metastasis ; Neoplasm Recurrence, Local ; Positron Emission Tomography Computed Tomography/methods ; Retrospective Studies
Czasopismo naukowe
Tytuł :
Hybridization chain reaction-mediated Fe 2 MoO 4 bimetallic nanozyme for colorimetric risk prediction of bladder cancer.
Autorzy :
Fu Y; Institute of Biomedical Engineering, College of Life Sciences, Qingdao University, Qingdao, 266071, China.
Zhao Z; Institute of Biomedical Engineering, College of Life Sciences, Qingdao University, Qingdao, 266071, China.
Shi Y; Institute of Biomedical Engineering, College of Life Sciences, Qingdao University, Qingdao, 266071, China.
Xu K; Institute of Biomedical Engineering, College of Life Sciences, Qingdao University, Qingdao, 266071, China.
Zhang J; Department of Urology, Key Laboratory of Urinary System Diseases, The Affiliated Hospital of Qingdao University, Qingdao, 266003, China.
Niu H; Department of Urology, Key Laboratory of Urinary System Diseases, The Affiliated Hospital of Qingdao University, Qingdao, 266003, China. Electronic address: .
Xu Y; Institute of Biomedical Engineering, College of Life Sciences, Qingdao University, Qingdao, 266071, China; Department of Urology, Key Laboratory of Urinary System Diseases, The Affiliated Hospital of Qingdao University, Qingdao, 266003, China. Electronic address: .
Pokaż więcej
Źródło :
Biosensors & bioelectronics [Biosens Bioelectron] 2022 Aug 15; Vol. 210, pp. 114272. Date of Electronic Publication: 2022 Apr 11.
Typ publikacji :
Journal Article
MeSH Terms :
Biosensing Techniques*/methods
Urinary Bladder Neoplasms*/diagnosis
Urinary Bladder Neoplasms*/genetics
Colorimetry/methods ; DNA ; Humans ; Reproducibility of Results
Czasopismo naukowe
Tytuł :
Neoadjuvant Programmed Cell Death Protein 1 and Chemotherapy in Combination in Muscle-Invasive Urothelial Cancer: Promising, But Not Deserving to Try Further.
Autorzy :
Zhang S; Sheng Zhang, MD, Shanghai Cancer Center and Shanghai Medical College, Fudan University, Shanghai, China.
Pokaż więcej
Źródło :
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2022 Aug 10; Vol. 40 (23), pp. 2656. Date of Electronic Publication: 2022 May 24.
Typ publikacji :
Letter
MeSH Terms :
Carcinoma, Transitional Cell*/drug therapy
Urinary Bladder Neoplasms*/drug therapy
Urinary Bladder Neoplasms*/surgery
Chemotherapy, Adjuvant ; Cystectomy ; Humans ; Muscles ; Neoadjuvant Therapy ; Neoplasm Invasiveness ; Programmed Cell Death 1 Receptor ; Treatment Outcome
Opinia redakcyjna
Tytuł :
Distinct Gene Mutations Are Associated With Clinicopathologic Features in Urachal Carcinoma.
Autorzy :
Zaleski MP; Department Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Chen H; Department Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Roy-Chowdhuri S; Department Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Patel KP; Department Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Luthra R; Department Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Routbort MJ; Department Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Kamat AM; Department Urology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Gao J; Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Siefker-Radtke A; Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Czerniak B; Department Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Guo CC; Department Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Pokaż więcej
Źródło :
American journal of clinical pathology [Am J Clin Pathol] 2022 Aug 04; Vol. 158 (2), pp. 263-269.
Typ publikacji :
Journal Article
MeSH Terms :
Carcinoma, Signet Ring Cell*/genetics
Carcinoma, Signet Ring Cell*/pathology
Urinary Bladder Neoplasms*/genetics
Urinary Bladder Neoplasms*/pathology
Adult ; Aged ; DNA Mutational Analysis ; Female ; Humans ; Male ; Middle Aged ; Mutation ; Proto-Oncogene Proteins p21(ras)/genetics
SCR Disease Name :
Urachal cancer
Czasopismo naukowe
Tytuł :
En Bloc Versus Conventional Transurethral Resection of Bladder Tumors: A Single-center Prospective Randomized Noninferiority Trial.
Autorzy :
Gallioli A; Department of Urology, Fundació Puigvert, Autonomous University of Barcelona, Barcelona, Spain.
Diana P; Department of Urology, Fundació Puigvert, Autonomous University of Barcelona, Barcelona, Spain; Department of Urology, Humanitas Research Hospital IRCCS, Rozzano, Italy. Electronic address: .
Fontana M; Department of Urology, Fundació Puigvert, Autonomous University of Barcelona, Barcelona, Spain.
Territo A; Department of Urology, Fundació Puigvert, Autonomous University of Barcelona, Barcelona, Spain.
Rodriguez-Faba Ó; Department of Urology, Fundació Puigvert, Autonomous University of Barcelona, Barcelona, Spain.
Gaya JM; Department of Urology, Fundació Puigvert, Autonomous University of Barcelona, Barcelona, Spain.
Sanguedolce F; Department of Urology, Fundació Puigvert, Autonomous University of Barcelona, Barcelona, Spain.
Huguet J; Department of Urology, Fundació Puigvert, Autonomous University of Barcelona, Barcelona, Spain.
Mercade A; Department of Urology, Fundació Puigvert, Autonomous University of Barcelona, Barcelona, Spain.
Piana A; Department of Urology, Fundació Puigvert, Autonomous University of Barcelona, Barcelona, Spain.
Aumatell J; Department of Urology, Fundació Puigvert, Autonomous University of Barcelona, Barcelona, Spain.
Bravo-Balado A; Department of Urology, Fundació Puigvert, Autonomous University of Barcelona, Barcelona, Spain.
Algaba F; Department of Pathology, Fundació Puigvert, Autonomous University of Barcelona, Barcelona, Spain.
Palou J; Department of Urology, Fundació Puigvert, Autonomous University of Barcelona, Barcelona, Spain; Department of Surgery, Autonomous University of Barcelona, Barcelona, Spain.
Breda A; Department of Urology, Fundació Puigvert, Autonomous University of Barcelona, Barcelona, Spain; Department of Surgery, Autonomous University of Barcelona, Barcelona, Spain.
Pokaż więcej
Źródło :
European urology oncology [Eur Urol Oncol] 2022 Aug; Vol. 5 (4), pp. 440-448. Date of Electronic Publication: 2022 May 23.
Typ publikacji :
Equivalence Trial; Journal Article; Randomized Controlled Trial
MeSH Terms :
Urinary Bladder Neoplasms*/pathology
Urinary Bladder Neoplasms*/surgery
Cystectomy ; Humans ; Prospective Studies ; Urinary Bladder/pathology ; Urinary Bladder/surgery ; Urologic Surgical Procedures/methods
Czasopismo naukowe
Tytuł :
Estimating National Exposures and Potential Bladder Cancer Cases Associated with Chlorination DBPs in U.S. Drinking Water.
Autorzy :
Weisman RJ; U.S. Environmental Protection Agency (U.S. EPA), Washington, DC, USA.
Heinrich A; U.S. Environmental Protection Agency (U.S. EPA), Washington, DC, USA.
Letkiewicz F; The Cadmus Group LLC, Waltham, Massachusetts, USA.
Messner M; U.S. Environmental Protection Agency (U.S. EPA), Washington, DC, USA.
Studer K; U.S. Environmental Protection Agency (U.S. EPA), Washington, DC, USA.
Wang L; U.S. Environmental Protection Agency (U.S. EPA), Washington, DC, USA.
Regli S; U.S. Environmental Protection Agency (U.S. EPA), Washington, DC, USA.
Pokaż więcej
Źródło :
Environmental health perspectives [Environ Health Perspect] 2022 Aug; Vol. 130 (8), pp. 87002. Date of Electronic Publication: 2022 Aug 01.
Typ publikacji :
Journal Article
MeSH Terms :
Disinfectants*/analysis
Drinking Water*
Urinary Bladder Neoplasms*/chemically induced
Urinary Bladder Neoplasms*/epidemiology
Water Pollutants, Chemical*/analysis
Water Purification*
Disinfection ; Halogenation ; Humans ; Trihalomethanes/analysis ; Trihalomethanes/toxicity ; United States/epidemiology
Czasopismo naukowe
Tytuł :
Identification of immune-related and autophagy-related genes for the prediction of survival in bladder cancer.
Autorzy :
Zhu Q; Department of Pharmacy, Affiliated Xiaoshan Hospital, Hangzhou Normal University, Hangzhou, 311201, China. .
Zhang L; Department of Pharmacy, Affiliated Xiaoshan Hospital, Hangzhou Normal University, Hangzhou, 311201, China.
Deng Y; Department of Pharmacy, Affiliated Xiaoshan Hospital, Hangzhou Normal University, Hangzhou, 311201, China.
Tang L; Department of Pharmacy, Affiliated Xiaoshan Hospital, Hangzhou Normal University, Hangzhou, 311201, China.
Pokaż więcej
Źródło :
BMC genomic data [BMC Genom Data] 2022 Aug 01; Vol. 23 (1), pp. 60. Date of Electronic Publication: 2022 Aug 01.
Typ publikacji :
Journal Article
MeSH Terms :
Gene Expression Regulation, Neoplastic*
Urinary Bladder Neoplasms*/genetics
Urinary Bladder Neoplasms*/mortality
Autophagy/genetics ; Humans ; Immunity/genetics ; Nomograms ; Prognosis ; Pyrin ; ras Guanine Nucleotide Exchange Factors
Czasopismo naukowe
Tytuł :
Bladder cancer in patients with neurogenic bladder disorder: a comparative study of different etiologies.
Autorzy :
Mühlbauer J; Department of Urology and Urological Surgery, University Medical Center Mannheim, University of Heidelberg, Theodor-Kutzer-Ufer 1-3, 68167, Mannheim, Germany. .
Klotz D; Department of Urology and Urological Surgery, University Medical Center Mannheim, University of Heidelberg, Theodor-Kutzer-Ufer 1-3, 68167, Mannheim, Germany.
Büttner S; Department for Biomathematics and Medical Statistics, Faculty of Medicine Mannheim of the University of Heidelberg, Theodor-Kutzer-Ufer 1-3, 68167, Mannheim, Germany.
Stein R; Center for Pediatric, Adolescent and Reconstructive Urology, University Medical Center Mannheim, University of Heidelberg, Theodor-Kutzer-Ufer 1-3, 68167, Mannheim, Germany.
Younsi N; Center for Pediatric, Adolescent and Reconstructive Urology, University Medical Center Mannheim, University of Heidelberg, Theodor-Kutzer-Ufer 1-3, 68167, Mannheim, Germany.
Pokaż więcej
Źródło :
World journal of urology [World J Urol] 2022 Aug; Vol. 40 (8), pp. 1929-1937. Date of Electronic Publication: 2022 Jan 15.
Typ publikacji :
Journal Article
MeSH Terms :
Spinal Cord Injuries*/complications
Urinary Bladder Neoplasms*
Urinary Bladder, Neurogenic*/etiology
Humans ; Urinary Bladder/pathology
Czasopismo naukowe
Tytuł :
Whether diagnostic ureteroscopic biopsy and ureteroscopy without biopsy have different impacts on intravesical recurrence of upper tract urothelial carcinoma after radical nephroureterectomy?
Autorzy :
Song Y; Department of Urology, Peking University People's Hospital, Beijing, 100044, China.
Han J; Department of Urology, Peking University People's Hospital, Beijing, 100044, China.
Qin C; Department of Urology, Peking University People's Hospital, Beijing, 100044, China.
Du Y; Department of Urology, Peking University People's Hospital, Beijing, 100044, China.
Xu T; Department of Urology, Peking University People's Hospital, Beijing, 100044, China. .
Pokaż więcej
Źródło :
World journal of urology [World J Urol] 2022 Aug; Vol. 40 (8), pp. 2135-2137. Date of Electronic Publication: 2022 May 28.
Typ publikacji :
Letter
MeSH Terms :
Carcinoma, Transitional Cell*/pathology
Carcinoma, Transitional Cell*/surgery
Ureteral Neoplasms*/pathology
Urinary Bladder Neoplasms*/pathology
Urinary Bladder Neoplasms*/surgery
Biopsy ; Humans ; Neoplasm Recurrence, Local/epidemiology ; Nephroureterectomy ; Retrospective Studies ; Ureteroscopy
Opinia redakcyjna
Tytuł :
Bladder Cancer in Neurogenic Patients.
Autorzy :
Phé V; Department of Urology, Assistance Publique-Hôpitaux de Paris, Tenon Academic Hospital, Sorbonne University, 4 Rue de la Chine, 75020, Paris, France. .
Pokaż więcej
Źródło :
World journal of urology [World J Urol] 2022 Aug; Vol. 40 (8), pp. 1895-1896.
Typ publikacji :
Editorial
MeSH Terms :
Urinary Bladder Neoplasms*/complications
Urinary Bladder Neoplasms*/therapy
Urinary Bladder, Neurogenic*/etiology
Urinary Bladder, Neurogenic*/therapy
Humans ; Urodynamics
Opinia redakcyjna
Tytuł :
CD93 orchestrates the tumor microenvironment and predicts the molecular subtype and therapy response of bladder cancer.
Autorzy :
Zheng X; Department of Urology, West China Hospital, Sichuan University, Chengdu, 610041, China; Institute of Urology, West China Hospital, Sichuan University, Chengdu, 610041, China; Institute of Systems Genetics, West China Hospital, Sichuan University, Chengdu, 610041, China.
Xu H; Department of Urology, West China Hospital, Sichuan University, Chengdu, 610041, China; Institute of Urology, West China Hospital, Sichuan University, Chengdu, 610041, China.
Lin T; Department of Urology, West China Hospital, Sichuan University, Chengdu, 610041, China; Institute of Urology, West China Hospital, Sichuan University, Chengdu, 610041, China.
Tan P; Department of Urology, West China Hospital, Sichuan University, Chengdu, 610041, China; Institute of Urology, West China Hospital, Sichuan University, Chengdu, 610041, China.
Xiong Q; Department of Urology, West China Hospital, Sichuan University, Chengdu, 610041, China; Institute of Urology, West China Hospital, Sichuan University, Chengdu, 610041, China.
Yi X; Department of Urology, West China Hospital, Sichuan University, Chengdu, 610041, China; Institute of Urology, West China Hospital, Sichuan University, Chengdu, 610041, China.
Qiu S; Department of Urology, West China Hospital, Sichuan University, Chengdu, 610041, China; Institute of Urology, West China Hospital, Sichuan University, Chengdu, 610041, China.
Yang L; Department of Urology, West China Hospital, Sichuan University, Chengdu, 610041, China; Institute of Urology, West China Hospital, Sichuan University, Chengdu, 610041, China.
Shen B; Institute of Systems Genetics, West China Hospital, Sichuan University, Chengdu, 610041, China.
Ai J; Department of Urology, West China Hospital, Sichuan University, Chengdu, 610041, China; Institute of Urology, West China Hospital, Sichuan University, Chengdu, 610041, China. Electronic address: .
Wei Q; Department of Urology, West China Hospital, Sichuan University, Chengdu, 610041, China; Institute of Urology, West China Hospital, Sichuan University, Chengdu, 610041, China. Electronic address: .
Pokaż więcej
Źródło :
Computers in biology and medicine [Comput Biol Med] 2022 Aug; Vol. 147, pp. 105727. Date of Electronic Publication: 2022 Jun 29.
Typ publikacji :
Journal Article
MeSH Terms :
Urinary Bladder Neoplasms*/genetics
Urinary Bladder Neoplasms*/therapy
Humans ; Immunotherapy ; Mutation ; Tumor Microenvironment
Czasopismo naukowe
Tytuł :
Re: bladder carcinomas in patients with neurogenic bladder and urinary schistosomiasis-are they the same tumors?
Autorzy :
Wishahi M; Urology Department, Theodor Bilharz Research Institute, Giza, 1124, Cairo, Egypt. .
Otto T; Urology Department, Rheinland Klinikum, Lukaskrankenhaus Neuss, Preußenstraße 84, 41464, Neuss, Germany.
Golka K; Leibniz Research Centre for Working Environment and Human Factors at TU Dortmund (IfADo), Dortmund, Germany.
Pokaż więcej
Źródło :
World journal of urology [World J Urol] 2022 Aug; Vol. 40 (8), pp. 2139-2140. Date of Electronic Publication: 2022 Jul 03.
Typ publikacji :
Letter
MeSH Terms :
Carcinoma*
Schistosomiasis haematobia*/complications
Schistosomiasis haematobia*/diagnosis
Urinary Bladder Neoplasms*/complications
Urinary Bladder Neoplasms*/pathology
Urinary Bladder, Neurogenic*/complications
Humans ; Urinary Bladder/pathology
Opinia redakcyjna
Tytuł :
All High-Grade Ta Tumors Should Be Classified as High Risk: Bacillus Calmette-Guérin Response in High-Grade Ta Tumors.
Autorzy :
Bree KK; Department of Urology, University of Texas MD Anderson Cancer Center, Houston, Texas.
Hensley PJ; Department of Urology, University of Texas MD Anderson Cancer Center, Houston, Texas.
Lobo N; Department of Urology, University of Texas MD Anderson Cancer Center, Houston, Texas.
Brooks NA; UPMC Urology of Central Pennsylvania, Harrisburg, Pennsylvania.
Nogueras-Gonzalez GM; Department of Biostatistics, University of Texas MD Anderson Cancer Center, Houston, Texas.
Guo CC; Department of Pathology, University of Texas MD Anderson Cancer Center, Houston, Texas.
Navai N; Department of Urology, University of Texas MD Anderson Cancer Center, Houston, Texas.
Grossman HB; Department of Urology, University of Texas MD Anderson Cancer Center, Houston, Texas.
Dinney CP; Department of Urology, University of Texas MD Anderson Cancer Center, Houston, Texas.
Kamat AM; Department of Urology, University of Texas MD Anderson Cancer Center, Houston, Texas.
Pokaż więcej
Źródło :
The Journal of urology [J Urol] 2022 Aug; Vol. 208 (2), pp. 284-291. Date of Electronic Publication: 2022 Jun 30.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms :
Mycobacterium bovis*
Urinary Bladder Neoplasms*/pathology
Adjuvants, Immunologic/therapeutic use ; Administration, Intravesical ; BCG Vaccine/therapeutic use ; Humans ; Neoplasm Invasiveness/pathology ; Neoplasm Recurrence, Local/pathology ; Neoplasm Staging
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies